Market Tracker

09/27 11:34am ET

ImmuCell Corp (NASDAQ:ICCC)

8.12
Delayed Data
As of 10:26am ET
 -0.089 / -1.08%
Today’s Change
5.60
Today|||52-Week Range
8.29
+7.71%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close8.21
Today’s open8.13
Day’s range8.12 - 8.17
Volume2,197
Average volume (3 months)5,836
Market cap$34.3M
Dividend yield--
Data as of 10:26am ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio26.2
Price/Sales2.32
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
VTGNVistaGen Therapeutic...+0.02+0.46%
CANFCan Fite Biopharma L...+0.08+3.08%
CLSNCelsion Corp-0.02-1.61%
CURNeuralstem Inc-0.00-1.28%
Data as of 11:33am ET, 09/27/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts